FDA Investigator Robert C Steyert

Robert C Steyert has inspections in 15 countries as of 03 Nov 2023. Robert C Steyert has collaborated with a combinined 6464 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
182
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Austria, Germany, Canada, France, Belgium, India, Italy, Netherlands, United Kingdom of Great Britain and Northern Ireland, Switzerland, Sweden, Norway, Czechia, Ireland
Co-Investigator(s):
Aaron L Dunbar, Alan P Kurtzberg, Alberto A Viciedo, Alia Legaux, Alice S Tsao, Allen F Hall, Althea A Williams, Amal M Mansour, Amatul H Marium, Amy Kim, Ana P Barido, Andrew F Cohen, Andrew J Barrowcliff, Andrew M Abramowitz, Ann B Okon, Ann M Stewart, Anna M Brannen, Anthony Orencia, MD, Arduino Frankovic, Arindam Dasgupta, PhD, Arthur G Hurst, Arthur T Ogdahl, Aziz A Mamur, Azza Talaat, Barbara M Frazier, Benton M Ketron, Bernardica T Sculac Stern, Bijoy Panicker, Bill Tacket, Jr, Bonita S Chester, Brandy N Lepage, Brenda W Uratani, PhD, Brunilda Torres, Byungja E Marciante, Carl J Montgomery, Cary Greene, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Chaoying C Ma, Charanjeet Jassal, Charisse K Green, Cheryl A Clausen, Christian Parra, Christie A Soto, Christina A Miller, Christine M Rivera, Christine M Smith, Christopher D Leach, Christopher S Fields, Christopher T Middendorf, Chunsheng Cai, PhD, Courtney N Long, Ct Viswanathan, PhD, Daniel J Lahar, Daniel L Aisen, Daniel L Zheng, Daryl A Dewoskin, David R Delucia, David R Heiar, David S Jackson, Dawn C Olenjack, Deborah J Parris, Demitria J Argiropoulos, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Deyaa Shaheen, Dilijeta Bajrami, Dipesh K Shah, Don H Bark, PhD, Donald G Gordon, Donald J Ullstrom, Dongping Dai, PhD, Douglas C Kovacs, Douglas Florentino, Douglas G Ng, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Edmund F Mrak, Jr, Edouard Viard, Elizabeth H Davis, Eric J Reisenauer, Erik W Koester, Erika V Butler, Erin D Mccaffery, Evan Tong, Evelyn Taha, Felix Maldonado, Frank Verni, Frederick Razzaghi, Gajendiran Mahadevan, PhD, Gam S Zamil, Ganesh N Joshi, Gary J Lader, Gary J Lehr, Gary T Greco, George J Flynn, Gerald Mierle, Geraldine D Sanders, Geraldine Sanders, Guerlain Ulysse, Harry J Brewer, Helen B Ricalde, Henry E Sanchez, Huascar Batista, Ilana Zigelman, Iram R Hassan, PhD, Irina Gaberman, Ivan E Reyes, Ivis Lnegron Torres, Jacqueline A O'shaughnessy, PhD, Jacqueline S Warner, Jai P Singh, Jaison J Eapen, James A Lane, James A Liubicich, James D Bridges, James L Dunnie, Jr, James M Kewley, James P Mcevoy, Jason D Tenney, Jay T Wong, Jeanne M Morris, Jeffrey A Sommers, Jeffrey B Medwid, PhD, Jennifer A Bazergui, Jennifer Alongie Vollom, Jennifer L Huntington, Jennifer Macmillan, Joanne E King, Joanne Heim, Joanne M Schlossin, John A Gonzalez, John A Iwen, John A Kadavil, PhD, John A Podsadowski, John P Mistler, Johnna L Bleem, Jonathan D Green, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose O Hernandez, Joseph Maselli, Joy P Matthias, Joy Rkozlowski Klena, Juan Rjimenez Garcia, Juanita P Versace, Judy Keihl, Justin A Boyd, Karen L Kosar, Karen M Kondas, Karishma G Gopaul, Karl Auguste, Katherine E Jacobitz, Katherine Szestypalow, Kathleen D Culver, Kathy E Craven, Kathy E Noe, Kazi Rafiquzzaman, Kenneth G Klobus, Kenneth H Williams, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kevin P Regan, Kham Phommachanh, Kim Lthomas Cruse, Kim M Downing, Kim Thomasc Rice, Kimberley A Ricketts, Kip J Hanks, Krishna Ghosh, PhD, Kristen D Evans, Kristina L Conroy, Kristy E Zuroski, Kwong P Lee, Larry K Austin, Lawrence W Farina, Leena Thomas, Leon L Law, Lesley K Satterwhite, Leslie A Cartmill, Libia M Lugo, Liming Zhang, Linda R Kuchenthal, Linda S Leja, Lisa M Bellows, Lisa M Smith, Lisa Mathew, LTJG Matthew R Palo, Lucas B Leake, Manhar R Patel, Marcellinus D Dordunoo, Margaret L Bolte, Margaret M Annes, Margaret M Sands, Maridalia Torres Irizarry, Marie A Fadden, Marie Bbuen Bigornia, Marie F Morin, Mark E Parmon, Mark Sassaman, Martin K Yau, PhD, Massoud Motamed, Matthew A Spataro, Matthew B Casale, Meghan Murphy, Melissa I Michurski, Melkamu Getie Kebtie, PhD, Meredith P Soehl, Investigator, Michael A Charles, Michael E Maselli, Michael Levin, Michael Serrano, Michael W Burd, Michele Gottshall, Michele L Obert, Michele Perry Williams, Michelle L Dragon Nagel, Miguel A Martinez, Mihaly S Ligmond, Mindy M Chou, Miral B Patel, Mohsen Rajabi Abhari, FDA, Mra B Kamberem, Mra Davism, Mra Digiuliod, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy A Saxenian Emmons, Nancy G Schmidt, Nancy N Bellamy, Nariman Patenaude, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas A Violand, Nicholas C Mendiola, Nicola M Fenty Stewart, Nicole A Lloyd, Nicole Vaught, Niketa Patel, Nilufer M Tampal, PhD, Noreen Muniz, Omadevi Somai, Investigator, Parul M Patel, Patricia H Dlugosz, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Paul L Figarole, Jr, Paul Mouris, Penny H Mccarver, Perez, Perry T Nichols, Peter Abel, Peter Caparelli, Peter M Trunk, Peter R Caparelli, Peter S Diak, Philip F Istafanos, DMV, MS, Phyllis J Wilson, Rachael A Moliver, Rafael Nevarez Nieves, Raihan A Chowdhury, Ramon A Hernandez, Ravindra K Kaallwal, Raymond L Cheung, Raymond T Oji, Reba A Gates, Richard Ferfoglia, Rober C Horan, PhD, Robert C Coleman, Robert C Howard, Robert E Moncayo, Robert J Martin, Rochelle K Kimmel, Ronald Ifraimov, Rose Xu, Russ E Davis, Russell J Glapion, Samina S Khan, Samuel T Walker, Sangeeta M Khurana, PhD, Santos E Camara, Sarah A Meehan, Sarah A Wangseng, Sarah Forney, Satheesh Thomas, Scott T Ballard, Shantelle I Hughes, Shari L Kahn, Sharon K Thoma, PharmD, Sharon L Matson, Shreya Shah, Simone E Pitts, Sixto M Mercado, Sixto M Mercado Rios, Sony Mathews, Sripal R Mada, PhD, Stanley Au, State Agency, Stefanie L Heckman, Stefanie L Kremer, Stephanie T Durso, Stephen D Brown, Steven C Madzo, Steven M Weinman, Steven P Donald, Sunita Vij, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susan M Joseph, Susan W Ting, Susanna E Ford, Analyst, Suwaskie S Smith, Syeda N Mahazabin, Tanya R Syffrard, Tara K Carmody, Tara K Normandin, Teresa I Navas, Terry Bridgewater, Theresa Kirkham (NMI), Thomas E Friel, Thomas J Arista, Thomas J Mooney, Thomas P Hansen, Thomas S Arista, Torrance J Slayton, Tracy M Portelli, Truong Xuan Nguyen (Andy), Uduak M Inokon, Valentino Fiorella, Valerie A Potopsingh, Valerie J Grecek Trinh, Vanessa M Williams, Verlinda A Narcisse, Vioela J Caze, Virginia L Meeks, Vivin George, Walden H Lee, Wayne E Seifert, Wayne S Fortenberry, Wei Huaemily Wu, Wendy G Tan, PhD, Wendy M Stone, William A Warnick, William J Leonard, Xiaokuang Lai, PhD, Xiaoping Guan, Xikui Chen (nmi), PhD, Yasamin Ameri, Yuyan Liang, Yvesna C Blaise, Yvonne M Santiago, Zachary L Miller

Robert C Steyert's Documents

Publish Date Document Type Title
March, 2010 FDA 483 Forest Research Institute Inc - Form 483, 2010-03-12
December, 2008 FDA 483 American Regent, Inc. - Form 483, 2008-12-16
April, 2014 FDA 483 Contract Pharmaceuticals Limited Canada - Form 483, 2014-04-11
October, 2004 EIR TIME CAP LABORATORIES, INC - EIR, 2004-10-01
August, 2014 FDA 483 OncoMed Pharmaceutical Services - Form 483, 2014-08-22
April, 2014 EIR Patheon Inc. - EIR, 2014-04-04
April, 2010 FDA 483 TIME CAP LABORATORIES, INC - Form 483, 2010-04-01
July, 2015 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2015-07-20
April, 2007 FDA 483 Amneal Pharmaceuticals of New York, LLC - Form 483, 2007-04-18
January, 2006 FDA 483 Response Epic Pharma, LLC - Form 483R, 2006-02-17
February, 2013 FDA 483 Coast Quality Pharmacy, LLC dba Anazao Health - Form 483, 2013-02-22
June, 2008 FDA 483 Cardinal Health 414, LLC - Form 483, 2008-06-26
December, 2008 EIR American Regent, Inc. - EIR, 2008-12-16
May, 2008 FDA 483 Generic Pharmaceutical Services inc. - Form 483, 2008-05-12
May, 2007 FDA 483 Biovail Contract Research - Form 483, 2007-05-10
August, 2016 FDA 483 Advanced Accelerator Applications (Italy) SRL - Form 483, 2016-08-12
April, 2013 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2013-04-04
September, 2011 FDA 483 LNK International, Inc. - Form 483, 2011-09-14
February, 2006 FDA 483 Schwarzkopf Micro Analy Lab - Form 483, 2006-02-06
January, 2003 FDA 483 Response Epic Pharma, LLC - Form 483R, 2003-01-28
November, 2011 FDA 483 Allegiant Health - Form 483, 2011-11-15
June, 2015 FDA 483 Pharbest Pharmaceuticals, Inc. - Form 483, 2015-06-08
April, 2007 FDA 483 Response Amneal Pharmaceuticals of New York, LLC - Form 483R, 2007-04-27
March, 2014 FDA 483 Region Care, Inc. - Form 483, 2014-03-20
January, 2005 FDA 483 Response Kenneth J. Rosenthal, M.D. - Form 483R, 2005-01-28
April, 2010 EIR TIME CAP LABORATORIES, INC - EIR, 2010-04-01
November, 2015 EIR Motzer, Robert J., M.D. - EIR, 2015-11-03
January, 2003 FDA 483 Epic Pharma, LLC - Form 483, 2003-01-16
August, 2016 FDA 483 Advanced Accelerator Applications (Italy) srl - Form 483, 2016-08-05
October, 2013 FDA 483 Hi-Tech Pharmacal Co., Inc. - Form 483, 2013-10-30
March, 2006 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2006-03-23
May, 2005 EIR Amneal Pharmaceuticals of New York, LLC - EIR, 2005-05-24
September, 2002 EIR New York Firefighters Skin Bank New York Presbyterian Hosp - EIR, 2002-09-20
May, 2005 FDA 483 Amneal Pharmaceuticals of New York, LLC - Form 483, 2005-05-24
November, 2007 FDA 483 P & L Development, LLC - Form 483, 2007-11-21
April, 2008 FDA 483 Citigroup Biomedical Imaging Center - Form 483, 2008-04-17
December, 2008 FDA 483 Response American Regent, Inc. - Form 483R, 2009-01-16
September, 2015 FDA 483 Body Blue 2006, Inc. - Form 483, 2015-09-11
May, 2005 FDA 483 Response Amneal Pharmaceuticals of New York, LLC - Form 483R, 2005-06-24
January, 2003 EIR Epic Pharma, LLC - EIR, 2003-01-16
February, 2013 FDA 483 Response Coast Quality Pharmacy, LLC dba Anazao Health - Form 483R, 2013-02-22
April, 2014 FDA 483 Jones Healthcare Group - Packaging Services, Inc - Form 483, 2014-04-16
June, 2011 FDA 483 Sciarra Laboratories, Inc. - Form 483, 2011-06-03
July, 2016 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2016-07-15
January, 2006 FDA 483 Epic Pharma, LLC - Form 483, 2006-01-25
November, 2015 FDA 483 Motzer, Robert J., M.D. - Form 483, 2015-11-03
November, 2006 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2006-11-09
October, 2010 FDA 483 Dana Tegzova, M.d. - Form 483, 2010-10-27
December, 2016 EIR Contract Pharmacal Corp. - EIR, 2016-12-09
March, 2008 FDA 483 TIME CAP LABORATORIES, INC - Form 483, 2008-03-04
August, 2009 EIR Douglas R. Labar, MD, PhD - EIR, 2009-08-05
August, 2012 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2012-08-17
June, 2016 FDA 483 Region Care, Inc. - Form 483, 2016-06-10
March, 2008 FDA 483 The Feinstein Institutes for Medical Research - Form 483, 2008-03-25
December, 2006 FDA 483 Gold Medal Hair Poducts, Inc. - Form 483, 2006-12-04
January, 2006 EIR Epic Pharma, LLC - EIR, 2006-01-25
March, 2012 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2012-03-02
March, 2008 EIR TIME CAP LABORATORIES, INC - EIR, 2008-03-04
June, 2012 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2012-06-14
February, 2010 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2010-02-19
May, 2013 FDA 483 The Feinstein Institutes for Medical Research - Form 483, 2013-05-09

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more